Switch theme
Sign up to access all valuation multiples
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
1998
1.5K+
LTM Revenue n/a
LTM EBITDA n/a
$267M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Sopharma Trading has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Sopharma Trading achieved revenue of $1.1B and an EBITDA of $57.4M.
Sopharma Trading expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Sopharma Trading valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $968M | $1.1B | XXX | XXX | XXX |
| Gross Profit | $96.5M | $110M | XXX | XXX | XXX |
| Gross Margin | 10% | 10% | XXX | XXX | XXX |
| EBITDA | $43.2M | $57.4M | XXX | XXX | XXX |
| EBITDA Margin | 4% | 5% | XXX | XXX | XXX |
| Net Profit | $5.3M | $16.9M | XXX | XXX | XXX |
| Net Margin | 1% | 2% | XXX | XXX | XXX |
| Net Debt | $102M | $97.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 13, 2025, Sopharma Trading's stock price is BGN 6 (or $3).
Sopharma Trading has current market cap of BGN 197M (or $114M), and EV of BGN 461M (or $267M).
See Sopharma Trading trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $267M | $114M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 13, 2025, Sopharma Trading has market cap of $114M and EV of $267M.
Sopharma Trading's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Sopharma Trading's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Sopharma Trading and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $267M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 4.6x | XXX | XXX | XXX |
| P/E | 4.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 9.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialSopharma Trading's NTM/LTM revenue growth is n/a
Sopharma Trading's revenue per employee for the last fiscal year averaged $0.8M, while opex per employee averaged n/a for the same period.
Over next 12 months, Sopharma Trading's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Sopharma Trading's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Sopharma Trading and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
| EBITDA Growth | 33% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | N/A | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.8M | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 0% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sopharma Trading acquired XXX companies to date.
Last acquisition by Sopharma Trading was XXXXXXXX, XXXXX XXXXX XXXXXX . Sopharma Trading acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Sopharma Trading founded? | Sopharma Trading was founded in 1998. |
| Where is Sopharma Trading headquartered? | Sopharma Trading is headquartered in Bulgaria. |
| How many employees does Sopharma Trading have? | As of today, Sopharma Trading has 1.5K+ employees. |
| Is Sopharma Trading publicy listed? | Yes, Sopharma Trading is a public company listed on BUL. |
| What is the stock symbol of Sopharma Trading? | Sopharma Trading trades under SFT ticker. |
| When did Sopharma Trading go public? | Sopharma Trading went public in 2008. |
| Who are competitors of Sopharma Trading? | Similar companies to Sopharma Trading include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Sopharma Trading? | Sopharma Trading's current market cap is $114M |
| What is the current revenue growth of Sopharma Trading? | Sopharma Trading revenue growth between 2023 and 2024 was 16%. |
| Is Sopharma Trading profitable? | Yes, Sopharma Trading is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
